Vivax malaria: neglected and not benign.
暂无分享,去创建一个
Nicholas J White | Shunmay Yeung | C. Guerra | R. Price | E. Tjitra | N. Anstey | N. White | S. Yeung | Nicholas M Anstey | Ric N Price | Carlos A Guerra | Emiliana Tjitra
[1] R. Price,et al. In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up , 2004, Antimicrobial Agents and Chemotherapy.
[2] M. Bangs,et al. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. , 2004, The Journal of infectious diseases.
[3] M. Abrahamowicz,et al. Epidemiology of malaria in a hypoendemic Brazilian Amazon migrant population: a cohort study. , 2004, The American journal of tropical medicine and hygiene.
[4] V. Sharma,et al. Epidemiology of malaria in pregnancy in central India , 1999, Bulletin of the World Health Organization.
[5] R. Peeling,et al. Evaluation of rapid diagnostic tests: malaria , 2006, Nature Reviews Microbiology.
[6] J. Soto,et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. , 2001, The American journal of tropical medicine and hygiene.
[7] H. Myint,et al. A systematic overview of published antimalarial drug trials. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[8] Comparing methods of estimating the global morbidity burden from Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.
[9] H. Q. Le,et al. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam * , 2002, Tropical medicine & international health : TM & IH.
[10] J. Wootton,et al. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. , 2001, The Journal of infectious diseases.
[11] Deepika Fernando,et al. Short-term impact of an acute attack of malaria on the cognitive performance of schoolchildren living in a malaria-endemic area of Sri Lanka. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[12] R. Price,et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.
[13] P. Chiodini,et al. Treatment of Plasmodium vivax malaria--time for a change? , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[14] M. Beg,et al. Cerebral involvement in benign tertian malaria. , 2002, The American journal of tropical medicine and hygiene.
[15] E. Tjitra,et al. Immunochromatographic Test for Detection of Plasmodium falciparum and Plasmodium vivax in Patients with a Presumptive Clinical Diagnosis of Malaria in Eastern Indonesia , 1999 .
[16] M. Singh,et al. Changing scenario of malaria in central India, the replacement of Plasmodium vivax by Plasmodium falciparum (1986–2000) , 2004, Tropical medicine & international health : TM & IH.
[17] C. Menéndez,et al. The sick placenta-the role of malaria. , 2004, Placenta.
[18] M. Alpers,et al. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum. , 1982, The American journal of tropical medicine and hygiene.
[19] Suradi,et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. , 1997, The American journal of tropical medicine and hygiene.
[20] Hilla Peretz,et al. Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .
[21] J. Baker,et al. Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations , 2002, Antimicrobial Agents and Chemotherapy.
[22] Myint-Oo,et al. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[23] N. White,et al. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. , 2004, Acta tropica.
[24] J. Baird,et al. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[25] J. Baird,et al. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. , 1998, The American journal of tropical medicine and hygiene.
[26] Jetsumon Sattabongkot,et al. Spatio-temporal distribution of Plasmodium falciparum and p. Vivax malaria in Thailand. , 2005, The American journal of tropical medicine and hygiene.
[27] R. Gilman,et al. Endemic malaria in the Peruvian Amazon region of Iquitos. , 2003, The American journal of tropical medicine and hygiene.
[28] S. Hoffman,et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine , 1993, The Lancet.
[29] A. Das,et al. Plasmodium vivax Malaria , 2005, Emerging infectious diseases.
[30] K. Maitland,et al. Plasmodium vivax: a cause of malnutrition in young children. , 1997, QJM : monthly journal of the Association of Physicians.
[31] A. Rodríguez-Morales,et al. Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? , 2006, The American journal of medicine.
[32] M. Dietrich,et al. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria , 2006, Tropical medicine & international health : TM & IH.
[33] B. Greenwood,et al. Overlap in the clinical features of pneumonia and malaria in African children. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[34] S. Hoffman,et al. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] S. Hoffman,et al. Primaquine therapy for malaria. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] R. Price,et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison , 2007, The Lancet.
[37] H. Webster,et al. The epidemiology of malaria in a Karen population on the western border of Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[38] G. Snounou,et al. The genetic diversity of Plasmodium vivax populations. , 2003, Trends in parasitology.
[39] K. Rieckmann,et al. PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE? , 1989, The Lancet.
[40] K. Mendis,et al. The impact of repeated malaria attacks on the school performance of children. , 2003, The American journal of tropical medicine and hygiene.
[41] E. Skerritt,et al. Spontaneous Rupture of the Spleen* , 1878, British medical journal.
[42] J. Baird,et al. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] S. Meshnick,et al. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. , 2004, The American journal of tropical medicine and hygiene.
[44] F. Nosten,et al. Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative , 2006, PLoS medicine.
[45] C. Newbold,et al. Plasmodium vevax and P. falciparum: Biological interactions and the possibility of cross-species immunity. , 1997, Parasitology today.
[46] J. Baird. Resurgent malaria at the millennium: control strategies in crisis. , 2000, Drugs.
[47] M. Postigo,et al. Acute non-cardiogenic lung injury in benign tertian malaria , 1997, The Lancet.
[48] N. White,et al. The epidemiology of severe malaria in an area of low transmission in Thailand. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[49] J. Roberts,et al. A retrospective examination of reinfection of humans with Plasmodium vivax. , 2004, The American journal of tropical medicine and hygiene.
[50] N. Hunt,et al. The Microcirculation in Severe Malaria , 2004, Microcirculation.
[51] J. Baker,et al. Efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in East Timor. , 2006, The American journal of tropical medicine and hygiene.
[52] R. Price,et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[53] K. Rieckmann,et al. Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic , 2003, Antimicrobial Agents and Chemotherapy.
[54] R. Ross,et al. SOME ENUMERATIVE STUDIES ON MALARIAL FEVER , 1910 .
[55] R. Price,et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[56] Purnomo,et al. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. , 1991, The American journal of tropical medicine and hygiene.
[57] R. Price,et al. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] J. Baird,et al. Chloroquine Resistance in Plasmodium vivax , 2004, Antimicrobial Agents and Chemotherapy.
[59] K. Kain,et al. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] P. Newton,et al. Mixed-species malaria infections in humans. , 2004, Trends in parasitology.
[61] Andrew J Tatem,et al. The global distribution and population at risk of malaria: past, present, and future. , 2004, The Lancet. Infectious diseases.
[62] R. Price,et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. , 2007, The Journal of infectious diseases.
[63] Kamolrat Silamut,et al. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. , 2004, The Journal of infectious diseases.
[64] K. Mendis,et al. The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.
[65] P. Newton,et al. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. , 2004, The American journal of tropical medicine and hygiene.
[66] J. Simpson,et al. Effects of Plasmodium vivax malaria in pregnancy , 1999, The Lancet.
[67] J. Roberts,et al. A retrospective examination of the effect of fever and microgametocyte count on mosquito infection on humans infected with Plasmodium vivax. , 2004, The American journal of tropical medicine and hygiene.
[68] S. Hoffman,et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. , 1995, The Journal of infectious diseases.
[69] G. Maguire,et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. , 2002, The Journal of infectious diseases.
[70] Anne Mills,et al. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. , 2004, The American journal of tropical medicine and hygiene.
[71] J. Karbwang,et al. High dose of primaquine in primaquine resistant vivax malaria. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[72] F. Nosten,et al. Evaluation of a new Plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[73] K. Mendis,et al. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[74] W. Wernsdorfer,et al. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[75] N. White,et al. Treatment of vivax malaria on the western border of Thailand. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[76] L. Miller,et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.
[77] H. Joshi,et al. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[78] S. Pukrittayakamee,et al. Pulmonary oedema in vivax malaria. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[79] K. Silamut,et al. Red cell selectivity in malaria: a study of multiple-infected erythrocytes. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[80] L. Rénia,et al. Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax: Evidence for Sequential Selection by Drug Pressure , 2003, Antimicrobial Agents and Chemotherapy.
[81] M. Alpers,et al. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea. , 1986, The American journal of tropical medicine and hygiene.
[82] Purnomo,et al. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. , 2003, The American journal of tropical medicine and hygiene.
[83] Simon I Hay,et al. Mapping the global extent of malaria in 2005. , 2006, Trends in parasitology.
[84] R. Price,et al. Factors contributing to anemia after uncomplicated falciparum malaria. , 2001, The American journal of tropical medicine and hygiene.
[85] Z. Şimşek,et al. Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey , 2004, Annals of tropical medicine and parasitology.
[86] J. Barnwell,et al. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. , 2006, The American journal of tropical medicine and hygiene.
[87] P. Nasveld,et al. Treatment of acute vivax malaria with tafenoquine. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[88] J. Sachs,et al. The economic burden of malaria. , 2001, The American journal of tropical medicine and hygiene.
[89] F. Ehrman,et al. PLASMODIUM VIVAX CHESSON STRAIN. , 1945, Science.
[90] J. Roberts,et al. A retrospective examination of anemia during infection of humans with Plasmodium vivax. , 2003, The American journal of tropical medicine and hygiene.
[91] K. Mendis,et al. Measuring malaria. , 2006, The American journal of tropical medicine and hygiene.
[92] D. Clyde,et al. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. , 1977, The American journal of tropical medicine and hygiene.
[93] J. Simpson,et al. Therapeutic Responses to Different Antimalarial Drugs in Vivax Malaria , 2000, Antimicrobial Agents and Chemotherapy.
[94] J. Baird,et al. Can primaquine therapy for vivax malaria be improved? , 2003, Trends in parasitology.
[95] Richard N. Price,et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study , 2000, The Lancet.